Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions

Perioperative chemotherapy improves overall survival in patients with oesophagogastric adenocarcinoma (OAC) and locoregional disease. The mainstay of perioperative chemotherapy in these patients is a platinum/fluoropyrimidine combination. The phase III FLOT4 trial has shown that the FLOT triplet reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Bose, Katrin, Franck, Caspar, Müller, Meike N., Canbay, Ali, Link, Alexander, Venerito, Marino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530426/
https://www.ncbi.nlm.nih.gov/pubmed/28785280
http://dx.doi.org/10.1155/2017/5651903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530426/
https://www.ncbi.nlm.nih.gov/pubmed/28785280
http://dx.doi.org/10.1155/2017/5651903

Ejemplares similares